N M Davies

Summary

Affiliation: University of Calgary
Country: Canada

Publications

  1. ncbi request reprint Clinical pharmacokinetics of naproxen
    N M Davies
    Faculty of Medicine, Department of Pharmacology and Therapeutics, University of Calgary, Alberta, Canada
    Clin Pharmacokinet 32:268-93. 1997
  2. ncbi request reprint Clinical pharmacokinetics of tiaprofenic acid and its enantiomers
    N M Davies
    Faculty of Medicine, Department of Pharmacology and Therapeutics, University of Calgary, Canada
    Clin Pharmacokinet 31:331-47. 1996
  3. ncbi request reprint Clinical pharmacokinetics of sulindac. A dynamic old drug
    N M Davies
    Faculty of Medicine, Department of Pharmacology and Therapeutics, University of Calgary, Alberta, Canada
    Clin Pharmacokinet 32:437-59. 1997
  4. ncbi request reprint Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls
    N M Davies
    Faculty of Medicine, Department of Pharmacology and Therapeutics, University of Calgary, Alberta, Canada
    Clin Pharmacokinet 33:184-213. 1997
  5. ncbi request reprint Clinical pharmacokinetics of nabumetone. The dawn of selective cyclo-oxygenase-2 inhibition?
    N M Davies
    Faculty of Medicine, Department of Pharmacology and Therapeutics, University of Calgary, Alberta, Canada
    Clin Pharmacokinet 33:404-16. 1997

Detail Information

Publications5

  1. ncbi request reprint Clinical pharmacokinetics of naproxen
    N M Davies
    Faculty of Medicine, Department of Pharmacology and Therapeutics, University of Calgary, Alberta, Canada
    Clin Pharmacokinet 32:268-93. 1997
    ..Although naproxen is excreted into breast milk the amount of drug transferred comprises only a small fraction of the maternal exposure. Significant drug interactions have been demonstrated for probenecid, lithium and methotrexate...
  2. ncbi request reprint Clinical pharmacokinetics of tiaprofenic acid and its enantiomers
    N M Davies
    Faculty of Medicine, Department of Pharmacology and Therapeutics, University of Calgary, Canada
    Clin Pharmacokinet 31:331-47. 1996
    ..Relationships between tiaprofenic acid concentrations in biological matrices and therapeutic or toxic effects have not yet been elucidated for this drug...
  3. ncbi request reprint Clinical pharmacokinetics of sulindac. A dynamic old drug
    N M Davies
    Faculty of Medicine, Department of Pharmacology and Therapeutics, University of Calgary, Alberta, Canada
    Clin Pharmacokinet 32:437-59. 1997
    ..Significant drug interactions have been demonstrated for dimethylsulphoxide, cyclosporin, furosemide (frusemide), hydrochlorothiazide, methotrexate and cholestyramine...
  4. ncbi request reprint Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls
    N M Davies
    Faculty of Medicine, Department of Pharmacology and Therapeutics, University of Calgary, Alberta, Canada
    Clin Pharmacokinet 33:184-213. 1997
    ..Significant drug interactions have been demonstrated for aspirin (acetylsalicylic acid), lithium, digoxin, methotrexate, cyclosporin, cholestyramine and colestipol...
  5. ncbi request reprint Clinical pharmacokinetics of nabumetone. The dawn of selective cyclo-oxygenase-2 inhibition?
    N M Davies
    Faculty of Medicine, Department of Pharmacology and Therapeutics, University of Calgary, Alberta, Canada
    Clin Pharmacokinet 33:404-16. 1997
    ..Dosage adjustment may be required in the elderly, patients with active rheumatic disease and those with hepatic impairment, but not in patients with mild-to-moderate renal failure...